Cytokine regulation of chronic cardiac allograft rejection: Evidence against a role for TH1 in the disease process

Transplantation

Volumn 67, Issue 12, 1999, Pages 1548-1555

  Piccotti, Joseph R ^a,b   Li, Kewang ^b   Chan, Sherri Y ^b   Eichwald, Ernst J ^c   Bishop, D Keith ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HELPER CELL; INTIMA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0033046769     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199906270-00008     Document Type: Article

References (29)

1. Orosz CG, Pelletier RP. Chronic remodeling pathology in grafts. Curr Opin Immunol 1997; 9: 676.
2. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Trans-plantation 1995; 59: 313.
3. Orosz CG, Wakely E, Sedmak DD, Bergese SD, VanBuskirk AM. Prolonged murine cardiac allograft acceptance. Characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody. Transplantation 1997; 63: 1109.
4. Orosz CG, Bergese SD, Wakely E, Xia D, Gordillo GM, VanBuskirk AM. Acute versus chronic graft rejection: Related manifestations of allosensitization in graft recipients. Transplant Rev 1997; 11: 38.
5. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141.
6. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection. An in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992; 10: 333.
7. Mottram PL, Han W-R, Purcell LJ, McKenzie IFC, Hancock WW. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-γ in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 1995; 59: 559.
8. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems: The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
9. Hancock WW, Shi C, Picard MH, Bianchi C, Russell ME. Lew-to-F344 carotid artery allografts. Analysis of a rat model of posttransplant vascular injury involving cell-mediated and humoral responses. Transplantation 1995; 60: 1565.
10. Bishop DK, Li W, Chan SY, Ensley RD, Shelby J, Eichwald EJ. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses. Transplantation 1994; 58: 576.
11. Pearson TC, Darby CR, Bushell AR, West LJ, Morris PJ, Wood KJ. The assessment of transplantation tolerance induced by anti-CD4 monoclonal antibody in the murine model. Transplantation 1993; 55: 361.
12. Orosz CG, Wakely E, Bergese SD, et al. Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody. Transplantation 1996; 61: 783.
13. Glysing-Jensen T, Räisänen-Sokolowski A, Sayegh MH, Russell ME. Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allograft. Transplantation 1997; 64: 1641.
14. Magram J, Connaughton SE, Warrier RR, et al. IL-12-deficient mice are defective in IFNγ production and Th1 cytokine responses. Immunity 1996; 4: 471.
15. Mattner F, Magram J, Ferrante J, et al. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 1996; 26: 1553.
16. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343.
17. Piccotti JR, Chan SY, Li K, Eichwald EJ, Bishop DK. Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-γ-producing cells. J Immunol 1997; 158: 643.
18. Piccotti JR, Li K, Chan SY, et al. Alloantigen-reactive Th1 development in IL-12-deficient mice. J Immunol 1998; 160: 1132.
19. Bishop DK, Orosz CG. Limiting dilution analysis for alloreactive, TCGF-secreting T cells. Two related LDA methods that discriminate between unstimulated precursor T cells and in vivo-alloactivated T cells. Transplantation 1989; 47: 671.
20. Orosz CG, Horstemeyer B, Zinn NE, Bishop DK. Development and evaluation of a limiting dilution analysis technique that can discriminate in vivo alloactivated cytotoxic T lymphocytes from their naive CTL precursors. Transplantation 1989; 47: 189.
21. Ryser JE, MacDonald HR. Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. J Immunol 1979; 122: 1691.
22. MacDonald HR, Cerottini JPC, Ryser J-E, et al. Quantitation and cloning of cytolytic T lymphocytes and their precursors. Immunol Rev 1980; 51: 93.
23. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 1981; 126: 1614.
24. Bishop DK, DeBruyne LA, Chan S, Xu S, Eichwald EJ. Dissociation of mouse cardiac transplant rejection and donor alloantigen-specific T cell responsiveness. Transplant Immunol 1995; 3: 222.
25. Konieczny BT, Dai Z, Elwood ET, et al. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998; 160: 2059.
26. Nagano H, Mitchell RN, Taylor MK, Hasegawa S, Tilney NL, Libby P. Interferon-γ deficiency prevents coronary arteriosclerosis by not myocardial rejection in transplanted mouse hearts. J Clin Invest 1997; 100: 550.
27. Mattner F, Magram J, Ferrante J, et al. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 1996; 26: 1553.
28. Mottram PL, Räisänen-Sokolowski A, Glysing-Jensen T, Stein-Oakley AN, Russell ME. Cardiac allografts from IL-4 knockout recipients: Assessment of transplant arteriosclerosis and peripheral tolerance. J Immunol 1998; 161: 602.
29. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.